MIDAZOLAM AGUETTANT 1 mg/ml, solution injectable — 10 ampoule(s) en verre de 5 ml (abrogée le 18/12/2021 (notification du 21/07/2021))
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400956487110 -
CIP7
5648711 -
CIS
66231933
What the source publishes
- Holder
- AGUETTANT
- Active ingredients
- MIDAZOLAM
- Form
- solution injectable pour perfusion ou
- Package
- 10 ampoule(s) en verre de 5 ml (abrogée le 18/12/2021 (notification du 21/07/2021))
- Routes
- intramusculaire, intraveineuse, rectale, sous-cutanée
- Administrative status
- cancelled
- Supply regime
- prescription limitée à 4 semaines ; délivrance fractionnée de 7 jours ; liste I ; prescription en toutes lettres sur ordonnance sécurisée
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2003-06-11
- Prescription
- Prescription or restricted
Names this record is found by
- MIDAZOLAM AGUETTANT 1 mg/ml, solution injectable — 10 ampoule(s) en verre de 5 ml (abrogée le 18/12/2021 (notification du 21/07/2021))
- MIDAZOLAM AGUETTANT 1 mg/ml, solution injectable
- MIDAZOLAM
Complete source data
{
"cis": "66231933",
"cip7": "5648711",
"form": "solution injectable pour perfusion ou",
"name": "MIDAZOLAM AGUETTANT 1 mg/ml, solution injectable — 10 ampoule(s) en verre de 5 ml (abrogée le 18/12/2021 (notification du 21/07/2021))",
"cip13": "3400956487110",
"holder": "AGUETTANT",
"routes": [
"intramusculaire",
"intraveineuse",
"rectale",
"sous-cutanée"
],
"holders": [
"AGUETTANT"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2003-06-11",
"compositions": [
{
"name": "MIDAZOLAM",
"nature": "SA",
"strength": "1 mg",
"linkageNumber": "1",
"substanceCode": "02667",
"dosageReference": "1 ml de solution injectable",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation abrogée",
"supplyRegime": "prescription limitée à 4 semaines ; délivrance fractionnée de 7 jours ; liste I ; prescription en toutes lettres sur ordonnance sécurisée",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "MIDAZOLAM AGUETTANT 1 mg/ml, solution injectable",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "10 ampoule(s) en verre de 5 ml (abrogée le 18/12/2021 (notification du 21/07/2021))",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2004-02-23",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "cancelled",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"MIDAZOLAM"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"prescription limitée à 4 semaines",
"délivrance fractionnée de 7 jours",
"liste I",
"prescription en toutes lettres sur ordonnance sécurisée"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "cancelled"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400956487110"